- Home
- ADM vs BNTX Comparison
ADM vs BNTX Comparison
Compare ADM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADM | BNTX |
|---|---|---|
| Founded | 1902 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ADM | BNTX |
|---|---|---|
| Price | $58.17 | $95.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 11 |
| Target Price | $55.67 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 2.6M | 1.6M |
| Earning Date | 02-03-2026 | 11-03-2025 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $83,211,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $4.44 | N/A |
| P/E Ratio | $23.52 | ★ N/A |
| Revenue Growth | N/A | ★ 3.70 |
| 52 Week Low | $40.98 | $81.20 |
| 52 Week High | $65.00 | $129.27 |
Technical Indicators
Market Signals| Indicator | ADM | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 46.63 |
| Support Level | $57.54 | $91.32 |
| Resistance Level | $58.10 | $96.19 |
| Average True Range (ATR) | 1.11 | 1.91 |
| MACD | -0.08 | 0.43 |
| Stochastic Oscillator | 29.09 | 62.99 |
Price Performance
Historical ComparisonAbout ADM Archer-Daniels-Midland Company
Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.